Pfizer, BioNTech ask FDA to expand approval of COVID vaccine to 12 to 15-year olds
Published
Published
'We have concluded that the Pfizer/BioNTech Covid-19 vaccine is safe and effective for five to 11-year olds'
Watch VideoThe U.S. is expanding COVID-19 boosters, ruling that 16- and 17-year-olds can get a third dose of Pfizer's..